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Nobel Prize Laureate: Ralph M. Steinman
(1943—2011)
2011 Nobel Prize
The immune system is an extraordinarily complex operation, employing numerous different
types of cells capable of recognizing harmful foreign substances, organizing a response,
carrying out attacks and ultimately guarding against future invasions. The coordination required
for such a system to work is gargantuan in scope and attests to a high degree of evolutionary
sophistication. In 1973, Rockefeller University scientist Ralph M. Steinman identified the cell
type that is almost singularly responsible for commanding the efforts of all other immune cells:
the dendritic cell. For this discovery, Dr. Steinman received the 2011 Nobel Prize in Physiology
or Medicine.
Immunity's chain of command begins with antigen-presenting cells, a class of cells that act as
sentinels, constantly on the lookout for unwelcome invaders, such as pathogenic viruses and
bacteria. Once they spot and corner an antigenic substance, they seize its weapon — the
antigenic compound — and break it down into pieces for closer examination. Each piece,
composed of a peptide, is then locked onto the surface of the antigen-presenting cell by an
assembly of molecules known as the major histocompatibility complex. It's then brought to the
attention of naïve T lymphocytes, cells that then send out signals to other immune cells waiting
to be called into action. B cells, when they receive orders, produce antibodies specific to that
individual antigen, and cytotoxic T cells execute cells that have been compromised — infected
— to keep the body's own resources from being used to aid and abet. Into the early 1970s,
immunologists believed that the chief antigen-presenting cells were macrophages, white blood
cells that form one regiment in the immune system. That view was turned on its ear soon after
Dr. Steinman joined Zanvil Cohn's Rockefeller laboratory as a postdoctoral fellow in 1970. While
investigating the production of antibodies in the spleen, Dr. Steinman noticed an unusual cell
that acted like a macrophage but looked nothing like it. Naming the newcomer "dendritic cell,"
for its branching, tree-like shape, Dr. Steinman was initially unaware of the significance of his
finding. However, his dedicated examinations of the cell over the next several years revealed
not a minor player but one that had been quietly running the show the whole time. Dr. Steinman
showed that dendritic cells, not macrophages, are the main T cell-stimulating cells. His in vivo
studies in the 1990s found that immature dendritic cells position themselves at places in the
body that are most vulnerable to invasion by microbes — the skin, the nasal passages and
throat, the intestines, the genitals — and wait until they are needed.
Then, as soon as a dendritic cell takes its first antigen prisoner, an incredible maturation
process takes place in which its armor is strengthened and its antigen-presenting and signaling
capabilities increase. He further demonstrated that in that first encounter, the chemical structure
of the antigen influences which genes are expressed in the dendritic cell's maturation process,
enabling it to draft a highly specific mission for T cells to put into action. And not only do DCs
train T cells how to fight foreign antigens, Dr. Steinman discovered, they also tolerize T cells to
harmless self-antigens.
Aside from single-handedly creating a new field of immunological research, Dr. Steinman's work
on dendritic cells has provided therapeutic possibilities for a number of serious diseases. The

ability of dendritic cells to defend the body against autoimmunity might be channeled for use in
the treatment of allergies, transplantations and autoimmune diseases like type 1 diabetes,
multiple sclerosis and psoriasis. Moreover, the techniques developed by Dr. Steinman to work
with dendritic cells effectively in a test tube have enabled the development of numerous
dendritic-cell tumor vaccines for various types of cancer, some of which are now in clinical trials.
CAREER
Dr. Steinman received his undergraduate degree from McGill University in 1963 and his M.D.
from Harvard Medical School in 1968. After an internship and residency at Massachusetts
General Hospital, he joined Rockefeller University in 1970 as a postdoc in the Laboratory of
Cellular Physiology and Immunology. He was appointed assistant professor in 1972, associate
professor in 1976 and professor in 1988. In 1995 he was named the Henry G. Kunkel Professor,
and in 1998 he was appointed director of the Christopher H. Browne Center for Immunology and
Immune Diseases. In addition to the Nobel Prize, Dr. Steinman received the Albany Medical
Center Prize in Medicine and Biomedical Research in 2009, the Albert Lasker Basic Medical
Research Award in 2007, the New York City Mayor's Award for Excellence in Science and
Technology in 2004 and the Gairdner Foundation International Award in 2003. He was a
member of the National Academy of Sciences and the Institute of Medicine. Dr. Steinman died
in 2011.

